Fletcher Payne - Net Worth and Insider Trading
Fletcher Payne Net Worth
The estimated net worth of Fletcher Payne is at least $12,920 dollars as of 2024-11-29. Fletcher Payne is the CFO of Catalyst Biosciences Inc and owns about 1,669 shares of Catalyst Biosciences Inc (CBIO) stock worth over $12,800. Fletcher Payne is also the SR VP & Chief Fin. Officer of Aptose Biosciences Inc and owns about 667 shares of Aptose Biosciences Inc (APTO) stock worth over $119. Details can be seen in Fletcher Payne's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Fletcher Payne has not made any transactions after 2022-09-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Fletcher Payne
Fletcher Payne Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Fletcher Payne owns 2 companies in total, including Catalyst Biosciences Inc (CBIO) , and Aptose Biosciences Inc (APTO) .
Click here to see the complete history of Fletcher Payne’s form 4 insider trades.
Insider Ownership Summary of Fletcher Payne
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CBIO | Catalyst Biosciences Inc | 2018-01-12 | Chief Financial Officer |
| APTO | Aptose Biosciences Inc | 2022-09-19 | SR VP & Chief Fin. Officer |
Fletcher Payne Latest Holdings Summary
Fletcher Payne currently owns a total of 2 stocks. Among these stocks, Fletcher Payne owns 1,669 shares of Catalyst Biosciences Inc (CBIO) as of December 17, 2015, with a value of $12,800 and a weighting of 99.08%. Fletcher Payne also owns 667 shares of Aptose Biosciences Inc (APTO) as of September 19, 2022, with a value of $119 and a weighting of 0.92%.
Latest Holdings of Fletcher Payne
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CBIO | Catalyst Biosciences Inc | 2015-12-17 | 1,669 | 7.67 | 12,800 |
| APTO | Aptose Biosciences Inc | 2022-09-19 | 667 | 0.18 | 119 |
Holding Weightings of Fletcher Payne
Fletcher Payne Form 4 Trading Tracker
According to the SEC Form 4 filings, Fletcher Payne has made a total of 0 transactions in Catalyst Biosciences Inc (CBIO) over the past 5 years. The most-recent trade in Catalyst Biosciences Inc is the acquisition of 667 shares on December 17, 2015, which cost Fletcher Payne around $20,000.
According to the SEC Form 4 filings, Fletcher Payne has made a total of 1 transactions in Aptose Biosciences Inc (APTO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Aptose Biosciences Inc is the acquisition of 667 shares on September 19, 2022, which cost Fletcher Payne around $6,800.
Insider Trading History of Fletcher Payne
- 1
Fletcher Payne Trading Performance
GuruFocus tracks the stock performance after each of Fletcher Payne's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Fletcher Payne is -21.05%. GuruFocus also compares Fletcher Payne's trading performance to market benchmark return within the same time period. The performance of stocks bought by Fletcher Payne within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Fletcher Payne's insider trading performs compared to the benchmark.
Performance of Fletcher Payne
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -7.77 | | | | | |
| Relative Return to S&P 500(%) | -1.19 | | | | | |
Fletcher Payne Ownership Network
Fletcher Payne Owned Company Details
What does Catalyst Biosciences Inc do?
Who are the key executives at Catalyst Biosciences Inc?
Fletcher Payne is the Chief Financial Officer of Catalyst Biosciences Inc. Other key executives at Catalyst Biosciences Inc include director & Chief Executive Officer Charles C Wu , director & President Songjiang Ma , and Chief Operating Officer Weiguo Ye .
Catalyst Biosciences Inc (CBIO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Catalyst Biosciences Inc (CBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Catalyst Biosciences Inc (CBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Catalyst Biosciences Inc (CBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Catalyst Biosciences Inc Insider Transactions
Fletcher Payne Mailing Address
Above is the net worth, insider trading, and ownership report for Fletcher Payne. You might contact Fletcher Payne via mailing address: 260 Littlefield Avenue, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
